{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:42:25Z","timestamp":1788838945315,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40263-025-01175-7","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:14:21Z","timestamp":1744294461000},"page":"527-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Residual Sleepiness in Obstructive Sleep Apnea Despite Continuous Positive Airway Pressure: A Systematic Review and\u00a0Network Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-6344","authenticated-orcid":false,"given":"Pongsakorn","family":"Tanayapong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7444-8674","authenticated-orcid":false,"given":"Visasiri","family":"Tantrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1648-4444","authenticated-orcid":false,"given":"Somprasong","family":"Liamsombut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7905-8392","authenticated-orcid":false,"given":"Sukanya","family":"Siriyotha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8197-6280","authenticated-orcid":false,"given":"Gareth","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-1308","authenticated-orcid":false,"given":"John","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-386X","authenticated-orcid":false,"given":"Ammarin","family":"Thakkinstian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"7","key":"1175_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jacc.2016.11.069","volume":"69","author":"S Javaheri","year":"2017","unstructured":"Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69(7):841\u201358.","journal-title":"J Am Coll Cardiol"},{"key":"1175_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fsurg.2018.00035","volume":"5","author":"AL D'Rozario","year":"2018","unstructured":"D\u2019Rozario AL, Field CJ, Hoyos CM, Naismith SL, Dungan GC, Wong KK, et al. Impaired neurobehavioural performance in untreated obstructive sleep apnea patients using a novel standardised test battery. Front Surg. 2018;5:35.","journal-title":"Front Surg"},{"issue":"1","key":"1175_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12955-020-01382-4","volume":"18","author":"LT Waldman","year":"2020","unstructured":"Waldman LT, Parthasarathy S, Villa KF, Bron M, Bujanover S, Brod M. Understanding the burden of illness of excessive daytime sleepiness associated with obstructive sleep apnea: a qualitative study. Health Qual Life Outcomes. 2020;18(1):128.","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"1175_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.5665\/sleep.2226","volume":"35","author":"CA Kushida","year":"2012","unstructured":"Kushida CA, Nichols DA, Holmes TH, Quan SF, Walsh JK, Gottlieb DJ, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the apnea positive pressure long-term efficacy study (APPLES). Sleep. 2012;35(12):1593\u2013602.","journal-title":"Sleep"},{"key":"1175_CR5","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Garc\u00eda MA, Capote F, Campos-Rodr\u00edguez F, Lloberes P, D\u00edaz de Atauri MJ, Somoza M, et al.; Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407-15.","DOI":"10.1001\/jama.2013.281250"},{"issue":"1","key":"1175_CR6","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.1038\/s41598-021-88642-5","volume":"11","author":"S Baillieul","year":"2021","unstructured":"Baillieul S, Wuyam B, P\u00e9rennou D, Tamisier R, Bailly S, Benmerad M, et al. A randomized sham-controlled trial on the effect of continuous positive airway pressure treatment on gait control in severe obstructive sleep apnea patients. Sci Rep. 2021;11(1):9329. https:\/\/doi.org\/10.1038\/s41598-021-88642-5.","journal-title":"Sci Rep"},{"issue":"4","key":"1175_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jsr.12039","volume":"22","author":"M Gasa","year":"2013","unstructured":"Gasa M, Tamisier R, Launois SH, Sapene M, Martin F, Stach B, et al. Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure. J Sleep Res. 2013;22(4):389\u201397.","journal-title":"J Sleep Res"},{"issue":"6","key":"1175_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/sleep\/30.6.711","volume":"30","author":"TE Weaver","year":"2007","unstructured":"Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007;30(6):711\u20139.","journal-title":"Sleep"},{"key":"1175_CR9","unstructured":"U.S. Food & Drug Administration. Supplemental NDA Approval for Provigil (Modafinil) Tablets in Obstructive Sleep Apnea\/Hypopnea Syndrome and Shift Work Sleep Disorder, January 23, 2004. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2004\/20717se1-008ltr.pdf. Accessed January 20, 2025."},{"key":"1175_CR10","unstructured":"U.S. Food & Drug Administration. NDA Approval for Nuvigil (Armodafinil) in Obstructive Sleep Apnea\/Hypopnea Syndrome, Narcolepsy, and Shift Work Sleep Disorder, June 15, 2007. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2007\/021875s000ltr.pdf. Accessed January 20, 2025"},{"key":"1175_CR11","unstructured":"U.S. Food & Drug Administration. NDA Approval for Sunosi (solriamfetol) in Narcolepsy and Obstructive Sleep Apnea, March 20, 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2019\/211230Orig1s000,%20Orig2s000ltr.pdf. Accessed January 20, 2025."},{"key":"1175_CR12","unstructured":"European Medicines Agency. Sunosi assessment report. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/sunosi-epar-public-assessment-report_en.pdf. Accessed January 20, 2025."},{"key":"1175_CR13","unstructured":"European Medicines Agency. European Medicines Agency recommends restricting the use of modafinil. July 22, 2010. https:\/\/www.ema.europa.eu\/en\/news\/european-medicines-agency-recommends-restricting-use-modafinil Accessed January 20, 2025."},{"key":"1175_CR14","unstructured":"European Medicines Agency. Ozawade assessment report. https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjv4of49_j-AhWaTmwGHWYlCRYQFnoECAgQAQ&url=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fdocuments%2Fassessment-report%2Fozawade-epar-public-assessment-report_en.pdf&usg=AOvVaw1-QZcML-aWcJ0sqnb-R4TA. Accessed January 20, 2025."},{"issue":"12","key":"1175_CR15","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.5664\/jcsm.9610","volume":"17","author":"S Ronnebaum","year":"2021","unstructured":"Ronnebaum S, Bron M, Patel D, Menno D, Bujanover S, Kratochvil D, et al. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea. J Clin Sleep Med. 2021;17(12):2543\u201355.","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"1175_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7326\/M22-3473","volume":"176","author":"T Pitre","year":"2023","unstructured":"Pitre T, Mah J, Roberts S, Desai K, Gu Y, Ryan C, et al. Comparative efficacy and safety of wakefulness-promoting agents for excessive daytime sleepiness in patients with obstructive sleep apnea: a systematic review and network meta-analysis. Ann Intern Med. 2023;176(5):676\u201384.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1175_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.","journal-title":"PLoS Med"},{"issue":"11","key":"1175_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"key":"1175_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898.","journal-title":"BMJ"},{"key":"1175_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2981","volume":"339","author":"SG Moreno","year":"2009","unstructured":"Moreno SG, Sutton AJ, Turner EH, Abrams KR, Cooper NJ, Palmer TM, et al. Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications. BMJ. 2009;339: b2981.","journal-title":"BMJ"},{"issue":"2","key":"1175_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0895-4356(99)00161-4","volume":"53","author":"A Thornton","year":"2000","unstructured":"Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53(2):207\u201316.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1175_CR22","first-page":"951","volume":"15","author":"IR White","year":"2015","unstructured":"White IR. Network meta-analysis. Stand Genom Sci. 2015;15(4):951\u201385.","journal-title":"Stand Genom Sci"},{"issue":"4","key":"1175_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1164\/ajrccm.163.4.2005036","volume":"163","author":"RN Kingshott","year":"2001","unstructured":"Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea\/hypopnea syndrome. Am J Respir Crit Care Med. 2001;163(4):918\u201323.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"1175_CR24","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1164\/ajrccm.164.9.2103032","volume":"164","author":"AI Pack","year":"2001","unstructured":"Pack AI, Black JE, Schwartz JR, Matheson JK. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med. 2001;164(9):1675\u201381.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1175_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1389-9457(03)00108-4","volume":"4","author":"DF Dinges","year":"2003","unstructured":"Dinges DF, Weaver TE. Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Med. 2003;4(5):393\u2013402.","journal-title":"Sleep Med"},{"issue":"4","key":"1175_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/sleep\/28.4.464","volume":"28","author":"JE Black","year":"2005","unstructured":"Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea\/hypopnea syndrome. Sleep. 2005;28(4):464\u201371.","journal-title":"Sleep"},{"issue":"2","key":"1175_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.pnpbp.2007.10.016","volume":"32","author":"LR Bittencourt","year":"2008","unstructured":"Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, et al. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2):552\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"1175_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5664\/jcsm.2912","volume":"9","author":"Y Inoue","year":"2013","unstructured":"Inoue Y, Takasaki Y, Yamashiro Y. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study. J Clin Sleep Med. 2013;9(8):751\u20137.","journal-title":"J Clin Sleep Med"},{"issue":"10","key":"1175_CR29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.sleep.2013.04.010","volume":"14","author":"WJ Herring","year":"2013","unstructured":"Herring WJ, Liu K, Hutzelmann J, Snavely D, Snyder E, Ceesay P, et al. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study. Sleep Med. 2013;14(10):955\u201363.","journal-title":"Sleep Med"},{"issue":"5","key":"1175_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","volume":"28","author":"T Roth","year":"2006","unstructured":"Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther. 2006;28(5):689\u2013706.","journal-title":"Clin Ther"},{"issue":"3","key":"1175_CR31","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.rmed.2006.06.007","volume":"101","author":"M Hirshkowitz","year":"2007","unstructured":"Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea\/hypopnea syndrome. Respir Med. 2007;101(3):616\u201327.","journal-title":"Respir Med"},{"issue":"1","key":"1175_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4088\/JCP.09m05536gry","volume":"71","author":"AD Krystal","year":"2010","unstructured":"Krystal AD, Harsh JR, Yang R, Rippon GA, Lankford DA. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. J Clin Psychiatry. 2010;71(1):32\u201340.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1175_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5664\/jcsm.3440","volume":"10","author":"DN Greve","year":"2014","unstructured":"Greve DN, Duntley SP, Larson-Prior L, Krystal AD, Diaz MT, Drummond SP, et al. Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study. J Clin Sleep Med. 2014;10(2):143\u201353.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"1175_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.chest.2018.11.005","volume":"155","author":"PJ Strollo Jr","year":"2019","unstructured":"Strollo PJ Jr, Hedner J, Collop N, Lorch DG Jr, Chen D, Carter LP, et al. Solriamfetol for the treatment of excessive sleepiness in OSA: a Placebo-Controlled Randomized Withdrawal Study. Chest. 2019;155(2):364\u201374.","journal-title":"Chest"},{"key":"1175_CR35","doi-asserted-by":"crossref","unstructured":"Schweitzer PK, Rosenberg R, Zammit GK, Gotfried M, Chen D, Carter LP, et al. Solriamfetol for excessive sleepiness in obstructive sleep apnea (TONES 3). A Randomized Controlled Trial. Am J Respir Crit Care Med. 2019;199(11):1421-31.","DOI":"10.1136\/bmjresp-2019-bssconf.4"},{"issue":"8","key":"1175_CR36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1513\/AnnalsATS.202002-136OC","volume":"17","author":"TE Weaver","year":"2020","unstructured":"Weaver TE, Drake CL, Benes H, Stern T, Maynard J, Thein SG, et al. Effects of solriamfetol on quality-of-life measures from a 12-week phase 3 randomized controlled trial. Ann Am Thorac Soc. 2020;17(8):998\u20131007.","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"1175_CR37","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.chest.2020.09.281","volume":"159","author":"JL P\u00e9pin","year":"2021","unstructured":"P\u00e9pin JL, Georgiev O, Tiholov R, Attali V, Verbraecken J, Buyse B, et al. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial. Chest. 2021;159(4):1598\u2013609.","journal-title":"Chest"},{"key":"1175_CR38","doi-asserted-by":"publisher","unstructured":"Dauvilliers Y, Craig SE, Bonsignore MR, Barb\u00e9 F, Verbraecken J, Asin J, et al.; HAROSA III Study Group. Pitolisant 40\u2009mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study. J Sleep Res. 2024:e14373. https:\/\/doi.org\/10.1111\/jsr.14373.","DOI":"10.1111\/jsr.14373"},{"issue":"10","key":"1175_CR39","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.5664\/jcsm.5096","volume":"11","author":"S Sukhal","year":"2015","unstructured":"Sukhal S, Khalid M, Tulaimat A. Effect of wakefulness-promoting agents on sleepiness in patients with sleep apnea treated with CPAP: a meta-analysis. J Clin Sleep Med. 2015;11(10):1179\u201386.","journal-title":"J Clin Sleep Med"},{"key":"1175_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.smrv.2015.10.005","volume":"30","author":"AB Avellar","year":"2016","unstructured":"Avellar AB, Carvalho LB, Prado GF, Prado LB. Pharmacotherapy for residual excessive sleepiness and cognition in CPAP-treated patients with obstructive sleep apnea syndrome: a systematic review and meta-analysis. Sleep Med Rev. 2016;30:97\u2013107.","journal-title":"Sleep Med Rev"},{"issue":"5","key":"1175_CR41","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1183\/13993003.01509-2015","volume":"47","author":"JL Chapman","year":"2016","unstructured":"Chapman JL, Vakulin A, Hedner J, Yee BJ, Marshall NS. Modafinil\/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis. Eur Respir J. 2016;47(5):1420\u20138.","journal-title":"Eur Respir J"},{"issue":"4","key":"1175_CR42","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.clinthera.2016.02.004","volume":"38","author":"YC Kuan","year":"2016","unstructured":"Kuan YC, Wu D, Huang KW, Chi NF, Hu CJ, Chung CC, et al. Effects of modafinil and armodafinil in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. Clin Ther. 2016;38(4):874\u201388.","journal-title":"Clin Ther"},{"issue":"9","key":"1175_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2165\/11315280-000000000-00000","volume":"29","author":"M Darwish","year":"2009","unstructured":"Darwish M, Kirby M, Hellriegel ET, Robertson P Jr. Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies. Clin Drug Investig. 2009;29(9):613\u201323.","journal-title":"Clin Drug Investig"},{"issue":"37","key":"1175_CR44","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1523\/JNEUROSCI.0857-07.2007","volume":"27","author":"Y Zhu","year":"2007","unstructured":"Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, et al. Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model. J Neurosci. 2007;27(37):10060\u201371.","journal-title":"J Neurosci"},{"issue":"1","key":"1175_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5665\/sleep.3306","volume":"37","author":"Y Li","year":"2014","unstructured":"Li Y, Panossian LA, Zhang J, Zhu Y, Zhan G, Chou YT, et al. Effects of chronic sleep fragmentation on wake-active neurons and the hypercapnic arousal response. Sleep. 2014;37(1):51\u201364.","journal-title":"Sleep"},{"key":"1175_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fneur.2015.00109","volume":"6","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Fenik P, Zhan G, Xin R, Veasey SC. Degeneration in arousal neurons in chronic sleep disruption modeling sleep apnea. Front Neurol. 2015;6:109.","journal-title":"Front Neurol"},{"key":"1175_CR47","doi-asserted-by":"crossref","unstructured":"Lal C, Weaver TE, Bae CJ, Strohl KP. Excessive daytime sleepiness in obstructive sleep apnea. Mechanisms and clinical management. Ann Am Thorac Soc. 2021;18(5):757-68.","DOI":"10.1513\/AnnalsATS.202006-696FR"},{"issue":"2","key":"1175_CR48","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1124\/jpet.118.248120","volume":"366","author":"MG Baladi","year":"2018","unstructured":"Baladi MG, Forster MJ, Gatch MB, Mailman RB, Hyman DL, Carter LP, et al. Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther. 2018;366(2):367\u201376.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1175_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.855","volume":"9","author":"S Krief","year":"2021","unstructured":"Krief S, Berrebi-Bertrand I, Nagmar I, Giret M, Belliard S, Perrin D, et al. Pitolisant, a wake-promoting agent devoid of psychostimulant properties: preclinical comparison with amphetamine, modafinil, and solriamfetol. Pharmacol Res Perspect. 2021;9(5): e00855.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"1175_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12874-018-0483-0","volume":"18","author":"CJ Weir","year":"2018","unstructured":"Weir CJ, Butcher I, Assi V, Lewis SC, Murray GD, Langhorne P, et al. Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review. BMC Med Res Methodol. 2018;18(1):25.","journal-title":"BMC Med Res Methodol"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01175-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01175-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01175-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T12:30:46Z","timestamp":1746621046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01175-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1175"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01175-7","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"26 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The database of studies and extracted data can be shared upon reasonable request to the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Open access funding provided by Mahidol University.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Pongsakorn Tanayapong: conceptualization, methodology, investigation, data curation, formal analysis, writing\u2014original draft preparation, writing\u2014review and editing, and visualization. Visasiri Tantrakul: conceptualization, methodology, investigation, data curation, formal analysis, writing\u2014original draft preparation, writing\u2014review and editing, and visualization. Somprasong Liamsombut: writing\u2014review and editing. Sukanya Siriyotha: data curation, software, formal analysis, visualization, and writing\u2014review and editing. Gareth McKay: writing\u2014review and editing. John Attia: writing\u2014review and editing. Ammarin Thakkinstian: conceptualization, methodology, formal analysis, supervision, and writing\u2014review and editing. All authors have read and approved the final version for submission and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}